H-rytvela-OH

Ref. 3D-PP47364

Produktinformation

• Name: H-rytvela-OH

Beschreibung

Peptide H-rytvela-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-rytvela-OH include the following: Pharmacological blockade of the interleukin-1 receptor suppressed Escherichia coli lipopolysaccharide-induced neuroinflammation in preterm fetal sheep Y Takahashi, T Takahashi, H Usuda , S Carter - American journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2589933323002665 Direct administration of the non-competitive interleukin-1 receptor antagonist rytvela transiently reduced intrauterine inflammation in an extremely preterm sheep Y Takahashi, M Saito, H Usuda , T Takahashi - Plos one, 2021 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0257847 99mTc-Labeled interleukin-1 antagonist peptide for inflammation imaging V Kulkarni, M Cai, C Barber, L Wan, J Woolfenden - 2013 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/54/supplement_2/1091.short Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes T Habelrih, Daca‰ Tremblay, E Di Battista, X Hou - American journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002937822008122 Born too small, too soon: how can we save them?: a novel interleukin-1 antagonist, Rytvela, successfully reverses the inflammatory cascade leading to intrauterine SE Loiselle - 2023 - papyrus.bib.umontreal.cahttps://papyrus.bib.umontreal.ca/xmlui/handle/1866/28301 Use of small peptides in the treatment of inflammatory diseases S Chemtob, Y Rosenstein , C Auvynet - Frontiers in Pharmacology, 2022 - frontiersin.orghttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1090014 AB041. A novel IL-1 receptor modulator prevents photoreceptor loss in a model of age-related macular degeneration R Dabouz, JC Rivera, S Chemtob - Annals of Eye Science, 2019 - aes.amegroups.orghttps://aes.amegroups.org/article/view/5246/html An allosteric interleukin-1 receptor modulator mitigates inflammation and photoreceptor toxicity in a model of retinal degeneration R Dabouz, CWH Cheng, P Abram , S Omri - Journal of , 2020 - Springerhttps://link.springer.com/article/10.1186/s12974-020-02032-8 A novel IL-1 receptor modulator prevents photoreceptor loss in a model of age-related macular degeneration R Dabouz, CJ Rivera - Ophthalmology & Visual , 2019 - iovs.arvojournals.orghttps://iovs.arvojournals.org/article.aspx?articleid=2744336 Examination of the active secondary structure of the peptide 101.10, an allosteric modulator of the interleukin-1 receptor, by positional scanning using beta-amino γ N Boutard, S Turcotte, K Beauregard - Journal of Peptide , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.1337 Novel noncompetitive IL-1 receptor-biased ligand prevents infection-and inflammation-induced preterm birth M Nadeau-Vallee , C Quiniou, J Palacios - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/195/7/3402/104929 Insertion of multiple alpha-amino γ-lactam (Agl) residues into a peptide sequence by solid-phase synthesis on synphase lanterns L Ronga , AG Jamieson , K Beauregard - Peptide Science , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.21288 Developpement de peptidomimetiques antagonistes du recepteur de l'interleukine-1beta K Beauregard - 2012 - papyrus.bib.umontreal.cahttps://papyrus.bib.umontreal.ca/xmlui/handle/1866/8460 Degree M. Sc.--Université de Montréal, 2012. K Beauregard - 2012 - dam-oclc.bac-lac.gc.cahttps://dam-oclc.bac-lac.gc.ca/download?is_thesis=1&oclc_number=969912441&id=b902d79e-b16f-4f44-9978-8051c8afa304&fileName=Beauregard_Kim_2012_memoire.pdf Microglia and interleukin-1beta in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A JC Rivera, N Sitaras, B Noueihed - , and vascular biology, 2013 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/ATVBAHA.113.301331 Recent advances in the prevention of preterm birth JA Keelan, JP Newnham - F1000Research, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516782/ PREVENTING PRETERM BIRTH AND IMPROVING INFANT OUTCOMES J Keelan - scientia.globalhttps://www.scientia.global/wp-content/uploads/2017/05/Jeff-Keelan.pdf Novel Noncompetitive IL-1 Receptor IIP Birth - 2015 - maternicarx.comhttps://maternicarx.com/wp-content/uploads/2021/05/JI-2015.pdf A leukocyte migration assay assists understanding of interleukin-1beta-induced leukocyte migration into preterm mouse uterus H Lee, V Patel, M Onushko, X Fang - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fphar.2022.898008/full SESSION 4: INNATE IMMUNE DEFENSES IN REPRODUCTIVE IMMUNOLOGY F Kuperwaser, G Avital, MJ Vaz, KN Noble - search.ebscohost.comhttps://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=10467408&asa=N&AN=156938863&h=6GDOHiscrivMDmtf2ASHIic338cwKBnRQQJX5cENBH2L9rblWBhqtMePTD6%2BR%2BDdamvpDL1ajvUmtM65BxVziw%3D%3D&crl=c Preventing Preterm Birth EI Solutions, J Sevigny, TL Augustina - Preterm Birth, an Issue , 2024 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=zQsLEQAAQBAJ&oi=fnd&pg=PA497&dq=(%22H-rytvela-OH%22+OR+%22rytvela%22)+AND+peptide&ots=IjlF_SEVwr&sig=Sav1ZFjWsRAJBFU5pyKAoC-pExI Novel anti-interleukin-1beta therapy preserves retinal integrity: a longitudinal investigation using OCT imaging and automated retinal segmentation in small rodents DN Sayah, TE Zhou , S Omri, J Mazzaferri - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fphar.2020.00296/full alpha-Amino-beta-hydroxy-γ-lactam for constraining peptide Ser and Thr residue conformation DJ St-Cyr , AG Jamieson , WD Lubell - Organic Letters, 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ol1000582 Interleukin-1 Receptor Modulators: Drawing Links between Structures, Biased Signaling, and in vivo Efficacy in Models of Preterm Birth and Retinopathy of CWH Cheng - 2019 - search.proquest.comhttps://search.proquest.com/openview/b981deabfa881710b89def150771bb32/1?pq-origsite=gscholar&cbl=18750&diss=y Development of a novel noncompetitive antagonist of IL-1 receptor C Quiniou, P Sapieha, I Lahaie, X Hou - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/180/10/6977/84065 Interleukin-1 and ischemic brain injury in the newborn: development of a small molecule inhibitor of IL-1 receptor C Quiniou, E Kooli, JS Joyal , P Sapieha - Seminars in , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0146000508000839 Landscape of preterm birth therapeutics and a path forward BS Coler, O Shynlova, A Boros-Rausch , S Lye - Journal of Clinical , 2021 - mdpi.comhttps://www.mdpi.com/2077-0383/10/13/2912 Evaluation of interleukin-1 and interleukin-6 receptor antagonists in a murine model of acute lung injury aca‰ Meunier, M Aubin vega, D Adam - Experimental , 2024 - Wiley Online Libraryhttps://physoc.onlinelibrary.wiley.com/doi/abs/10.1113/EP091682 Interleukin-1 receptor modulation using beta-substituted alpha-amino-γ-lactam peptides from solid-phase synthesis and diversification A Geranurimi, CWH Cheng, C Quiniou, F CacaÂŽte - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fchem.2020.610431/full

• Marke: Biosynth